Temglip is an oral antidiabetic medicine used in the management of type 2 diabetes mellitus. It belongs to the sulfonylurea class and works by stimulating the pancreas to release insulin, thereby helping to lower elevated blood glucose levels. Temglip is commonly prescribed when diet, exercise, and lifestyle modifications alone are insufficient to achieve adequate glycemic control. Effective blood sugar management with Temglip helps reduce the risk of long-term diabetic complications affecting the cardiovascular system, kidneys, nerves, and eyes. It may be used alone or in combination with other antidiabetic therapies as part of a comprehensive diabetes care plan. Temglip supports improved metabolic control and contributes to better overall health outcomes in patients with type 2 diabetes.